Literature DB >> 15649307

Assessment of the cag pathogenicity island status of Helicobacter pylori infections with serology and PCR.

M Kivi1, Y Tindberg, C Bengtsson, L Engstrand, M Granström.   

Abstract

The serological characterisation of Helicobacter pylori strains has been questioned, e.g., when the presence or absence of the cag pathogenicity island (PAI) is determined. This study compared CagA-reactive serum antibodies, assessed with immunoblot, with cag PAI status, as determined by PCR. CagA serology results were available for 101 individuals contributing 202 bacterial samples for cag PAI PCR. There was a high degree of correlation between the two methods (kappa coefficient, 0.82; 95% confidence interval, 0.68-0.97). Combined with suggested biological explanations for the discrepancies, this finding supports the application of well-evaluated serological assays in the assessment of the cag PAI status of H. pylori infections in clinical and epidemiological studies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15649307     DOI: 10.1111/j.1469-0691.2004.01021.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  3 in total

1.  Detection of H. pylori infection by ELISA and Western blot techniques and evaluation of anti CagA seropositivity in adult Turkish dyspeptic patients.

Authors:  Ozlem Yilmaz; Nazime Sen; Ahmet Ali Küpelioğlu; Ilkay Simşek
Journal:  World J Gastroenterol       Date:  2006-09-07       Impact factor: 5.742

2.  Evaluation of a commercial immunoblot, Helicoblot 2.1, for diagnosis of Helicobacter pylori infection.

Authors:  Lea Veijola; Aino Oksanen; Pentti Sipponen; Hilpi Rautelin
Journal:  Clin Vaccine Immunol       Date:  2008-09-30

3.  Helicobacter pylori genome variability in a framework of familial transmission.

Authors:  Mårten Kivi; Sandra Rodin; Ilya Kupershmidt; Annelie Lundin; Ylva Tindberg; Marta Granström; Lars Engstrand
Journal:  BMC Microbiol       Date:  2007-06-11       Impact factor: 3.605

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.